SCHEMBL1660445

SCHEMBL1660445

CC1CCc2c(Oc3nc([C]=O)co3)cccc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 9/20 0.36
MAOA P21397 3/20 0.33
MAOB P27338 3/20 0.33
BCHE P06276 3/20 0.33
PTK2 Q05397 2/20 0.32
CYP19A1 P11511 1/20 0.32
MEN1 O00255 2/20 0.31
CYP1A2 P05177 2/20 0.31
HTR1A P08908 2/20 0.31
DRD2 P14416 2/20 0.31
DRD4 P21917 2/20 0.31
DRD3 P35462 2/20 0.31
HTR5A P47898 2/20 0.31
KMT2A Q03164 2/20 0.31
TSHR P16473 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA1A P35348 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660051 0.85 ACHE (0.36) ACHEMAOAMAOBBCHE
SCHEMBL1660068 0.81 ACHE (0.35) ACHEMAOAMAOBBCHEPTK2
SCHEMBL1658929 0.74 TAS1R3 (0.38)
SCHEMBL12563329 0.68 PDE2A (0.41) PTK2
SCHEMBL17014300 0.68 HTR1A (0.55) ACHECYP19A1MEN1CYP1A2HTR1A
SCHEMBL2866447 0.67 KDM4C (0.36) ACHEMAOAMAOBBCHE
SCHEMBL1660451 0.66 HTR2C (0.36) HTR1ADRD2ADRA1A
SCHEMBL2866959 0.65 TTR (0.33) ACHEMAOAMAOBBCHEDRD2
SCHEMBL1660099 0.64 AR (0.33)
SCHEMBL13563794 0.62 HSD11B1 (0.42) MEN1CYP1A2HTR1ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed